|
11/03/2011
Contact: Debbie Putt, Communications and Outreach Manager
New Mexico Cancer Care Alliance
505-925-0365
New Mexico Cancer Care Alliance Welcomes New Participant
The New Mexico Cancer Care Alliance Board of Directors voted to approve Jeffrey Hanrahan, M.D. from Presbyterian Healthcare Services as a participant.
New Mexico Cancer Care Alliance, a 501(c)(3) charitable organization, offers New Mexico cancer patients and physicians access to the most up-top-date clinical research studies in cancer treatment. Our network of the major healthcare systems in Northern, Central, and Southern New Mexico and most of the community oncology professionals allows cancer patients to receive quality healthcare locally while increasing the knowledge of cancer care globally.
###
Please see our "Board of Directors" page for a full list of NMCCA's Board members.
Past Press Releases:
November 2011 NMCCA Board of Directors Meeting
August 2011 NMCCA Board of Directors Meeting
May 2011 NMCCA Board of Directors Meeting
March 2011 NMCCA Board of Directors Meeting
November 2010 NMCCA Board of Directors Meeting
September 2010 NMCCA Executive Board of Directors Meeting
May 2010 NMCCA Board of Directors Meeting
February 2010 NMCCA Board of Directors Meeting
October 2009 NMCCA Board of Directors Meeting
August 2009 NMCCA Board of Directors Meeting
May 2009 NMCCA Board of Directors Meeting
February 2009 NMCCA Board of Directors Meeting
November 2008 NMCCA Board of Directors Meeting
August 2008 NMCCA Board of Directors Meeting
June 2008 NMCCA Board of Directors Meeting
February 2008 NMCCA Board of Directors Meeting
May 2007 NMCCA Board of Directors Meeting
September 2006 NMCCA Board of Directors Meeting
July 2006 NMCCA Board of Directors Meeting
March 2006 NMCCA Board of Directors Meeting
September 2005 NMCCA Board of Directors Meeting
August 2005 NMCCA Board of Directors Meeting
Additional Past Press Releases
Lance Armstrong May Not Be Coming To New Mexico, But The Doctor Who Cured Him Is!
Northern New Mexico Cancer Patients Now Have Access to Cancer Clinical Trials
|
